Bragar Eagel & Squire, P.C. Is Investigating Establishment,
NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating...
Source: globenewswire.com
📰 Accelerate Diagnostics News
Page 9 - Accelerate Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Accelerate Diagnostics. Real-time updates on events, politics, business and more.
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Accelerate Diagnostics, Inc. (AXDX) on Behalf of Investors
Glancy Prongay & Murray LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Accelerate Diagnostics, Inc. investors... | October 27, 2022
Bloomberg Businessweek Charlesh Linehan Glancy Prongay Murray Drug Administration Associated Press Whistleblower Program
Source: marketscreener.com
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Accelerate Diagnostics, Inc. Investors to Inquire About Securities Class Action Investigation - AXDX
NEW YORK, Oct. 26, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor... | October 26, 2022
Source: marketscreener.com
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Accelerate Diagnostics, Inc. Investors to Inquire About Securities Class Action Investigation
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of...
Source: prnewswire.com
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Accelerate Diagnostics, Inc. (AXDX) on Behalf of Investors
26.10.2022 - Law Offices of Howard G. Smith announces an investigation on behalf of Accelerate Diagnostics, Inc. (“Accelerate” or the “Company”) (NASDAQ: AXDX) investors concerning the Company’s possible violations of federal securities laws. On October 21, ...
United States Bristol Pike Howardg Smith Law Offices Attorney Advertising Accelerate Diagnostics Stock
Source: wallstreet-online.de
Accelerate Diagnostics scheduled call to review 2022 third quarter results
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Monday, November 14, 2022, at 4:30 p....
Diagnostics Inc Prnewswire Accelerate Diagnostics Inc Elite Entry Number Accelerate Diagnostics Accelerate Pheno
Source: prnewswire.com
Urinary Tract Infection Testing Market Research Report by
The Global Urinary Tract Infection Testing Market size was estimated at USD 471. 23 million in 2021 and expected to reach USD 518. ...
Source: globenewswire.com
Global Antimicrobial Susceptibility Testing Market Drivers, Trends And Restraints For 2022-2031
The Business Research Company’s Antimicrobial Susceptibility Testing Global Market Report 2022: Market Size, Trends, And Forecast To 2026
Source: einnews.com
Accelerate Diagnostics Announces Pricing of Public Offering of Common Stock
/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) ("Accelerate Diagnostics") today announced the pricing of an underwritten public offering of...
United States Riverside Plaza Oppenheimer Co Craig Hallum Capital Group William Blair Company Exchange Commission
Source: prnewswire.com
BD, Accelerate Diagnostics partner on rapid antibiotic testing
BD (NYSE:BDX) announced that it entered into a worldwide commercial collaboration agreement with Accelerate Diagnostics (Nasdaq:AXDX).
United Kingdom Jack Phillips Action Fund Accelerate Diagnostics Antimicrobial Resistance Accelerate Pheno
Source: massdevice.com